SCHEMBL5111434

SCHEMBL5111434

CC(O)c1c(N)cccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
TSHR P16473 3/20 0.44
NR4A2 P43354 3/20 0.43
CYP3A4 P08684 2/20 0.41
PIK3CA P42336 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
NFKB1 P19838 1/20 0.39
PNMT P11086 1/20 0.39
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.38
DRD2 P14416 2/20 0.35
DRD3 P35462 2/20 0.35
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
AOC3 Q16853 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
JAK1 P23458 1/20 0.33
SLC6A2 P23975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23212908 0.84 CYP1A2 (0.41) ALDH1A1TSHRCYP3A4CYP1A2CYP2D6
SCHEMBL28820045 0.84 CYP1A2 (0.41) ALDH1A1TSHRCYP3A4CYP1A2CYP2D6
SCHEMBL4852014 0.84 CYP3A4 (0.43) ALDH1A1TSHRCYP3A4PIK3CACYP1A2
SCHEMBL2292937 0.84 CYP1A2 (0.41) ALDH1A1TSHRCYP3A4CYP1A2CYP2D6
SCHEMBL3790528 0.83 ALDH1A1 (0.52) ALDH1A1TSHRNR4A2CYP3A4PIK3CA
SCHEMBL5118561 0.79 ALDH1A1 (0.44) ALDH1A1TSHRNR4A2CYP3A4PIK3CA
SCHEMBL1464678 0.78 CYP3A4 (0.39) ALDH1A1TSHRCYP3A4PIK3CACYP1A2
SCHEMBL8973695 0.77 CD44 (0.48) ALDH1A1TSHRCYP3A4PIK3CACYP1A2
SCHEMBL19971983 0.77 TSHR (0.48) ALDH1A1TSHRCYP3A4CYP1A2CYP2D6
SCHEMBL19979060 0.77 ALDH1A1 (0.37) ALDH1A1TSHRCYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442696-B2 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses LIGAND PHARMACEUTICALS, INC. (US) 2008-10-28 US disclosed
US-20070197520-A1 MINERALOCORTICOID RECEPTOR MODULATOR COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USES LIGAND PHARMACEUTICALS INC. 2007-08-23 US disclosed
WO-2006010142-A2 MINERALOCORTICOID RECEPTOR MODULATOR COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE LIGAND PHARMACEUTICALS, INC. (US) 2006-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197520-A1 MINERALOCORTICOID RECEPTOR MODULATOR COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AND THEIR USES NR3C2, MC2R, NR3C1 ALDH1A1 3693/4885TSHR 66/4885NR4A2 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.